Blog

Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Photo from CPE/LinkedIn

Jul 11, 2024, 15:38

Call to Action on the implementation of Joint Clinical Assessment for ATMPs

Cancer Patients Europe (CPE) shared on LinkedIn:

“CPE, in collaboration with the Alliance for Regenerative Medicine and Fondazione Telethon, has launched a Call to Action on the implementation of the EU Joint Clinical Assessment (JCAs) for Advanced Therapy Medicinal Products (ATMPs).

With the support of more than 30 signatories, we are urging the HTA Coordination Group and JCA assessors to ensure that JCA methodologies do not hinder Patient Access and the innovation of ATMPs in Europe.

Read the press release.”

Source: CPE/LinkedIn

Alliance for Regenerative Medicine ATMPs cancer Cancer Patients Europe CPE Fondazione Telethon HTA Coordination Group JCA Joint Clinical Assessment OncoDaily Oncology

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage